Acessibilidade / Reportar erro

Anesthesia management in a child with osteogenesis imperfecta and epidural

Abstracts

Osteogenesis Imperfecta (OI) results from gene mutation that causes defective or insuffi cient collagen formation. It may cause various anesthetic complications due to the diffi culty in airway management, existence of spinal deformity, respiratory disorders, cardiac anomalies, thrombocyte function disorder, risk of hyperthermia, bacillary invagination, bone deformities and metabolic disorders. The anesthesia management of OI patients should be exercised with caution given certain risks of respiratory disorders. These risks are due to thorax deformity, bone fractures during moving or changing position, mandibular and cervical fractures related with intubation, diffi cult intubation and malignant hyperthermia. The anesthetic technique using Total Intravenous Anesthesia (TIVA) and laryngeal mask airway is suitable for pediatric patient care with OI. However, these techniques have not yet been reported as useful in neurosurgery case reports. In this study, we present the use of TIVA and ProSeal Laringeal Mask in a child with OI and epidural hemorrhage. We came to the conclusion that LMA and TIVA can safely be used in the anesthetic management of OI patients with severe anesthetic problems.

Anesthesia; Anesthesia, Intravenous; Hematoma, Epidural, Cranial; Laryngeal Masks; Osteogenesis Imperfect


Osteogênese imperfeita (OI) é o resultado de uma mutação genética que causa a formação defeituosa ou insuficiente de colágeno. OI pode causar várias complicações anestésicas por causa do manejo difícil das vias aéreas, da presença de deformidade da coluna vertebral, de doenças respiratórias, anomalias cardíacas, distúrbio da função plaquetária, risco de hipertermia, invaginação bacilar, deformidades ósseas e distúrbios metabólicos. A abordagem anestésica de pacientes com OI deve ser feita com cautela, por causa do risco de certas complicações respiratórias. Esses riscos são causados por deformidade do tórax, fraturas ósseas durante o movimento ou mudança de posição, fraturas mandibulares e cervicais relacionadas à intubação, intubação difícil e hipertermia maligna. As técnicas anestésicas com o uso de anestesia venosa total (AVT) e máscara laríngea são adequadas para o manejo de paciente pediátrico com OI. No entanto, essas técnicas ainda não foram mencionadas como úteis em relatos de casos neurocirúrgicos. Neste estudo, apresentamos o uso de AVT e máscara laríngea ProSeal (MLP) em uma criança com OI e hemorragia epidural. Concluímos que a MLP e a AVT podem ser usadas com segurança no manejo anestésico de pacientes com OI e problemas anestésicos graves.

DOENÇAS, Óssea; EQUIPAMENTOS, Máscara laríngea; Osteogênese Imperfeita; Hematoma Epidural Craniano; TÉCNICAS ANESTÉSICAS, Geral, venosa


La osteogénesis imperfecta (OI) es el resultado de una mutación genética que causa la formación defectuosa o insufi ciente de colágeno. La OI puede causar varias complicaciones anestésicas a causa del manejo difícil de las vías aéreas, de la presencia de deformidad de la columna vertebral, de enfermedades respiratorias, anomalías cardíacas, trastorno de la función plaquetaria, riesgo de hipertermia, invaginación bacilar, deformidades óseas y trastornos metabólicos. El abordaje anestésico de pacientes con OI debe ser hecho con cautela, ya que existe un riesgo de ciertas complicaciones respiratorias. Esos riesgos son causados por deformidad del tórax, fracturas óseas durante el movimiento o el cambio de posición, fracturas mandibulares y cervicales relacionadas con la intubación, intubación difícil e hipertermia maligna. Las técnicas anestésicas con el uso de anestesia venosa total (AVT) y mascarilla laríngea, son adecuadas para el manejo de paciente pediátrico con OI. Sin embargo, esas técnicas todavía no han sido mencionadas como útiles en relatos de casos neuroquirúrgicos. En este estudio, presentamos el uso de AVT y mascarilla laríngea ProSeal (MLP) en un niño con OI y hemorragia epidural. Concluimos que la MLP y la AVT pueden ser usadas con seguridad en el manejo anestésico de pacientes con OI y problemas anestésicos graves.

ENFERMIDADES, Huesso; EQUIPOS, Mascarilla laríngea; Hematoma Peridural Craniano; Osteogénesis Imperfecta; TÉCNICAS ANESTÉSICAS, General, intravenosa


CLINICAL INFORMATION

IMD; Assistant Anesthesia Professor, Department of Anesthesiology and Reanimation, Inonu University School of Medicine, Malatya, Turkey

IIMD; Anesthesia Professor, Department of Anesthesiology and Reanimation, Inonu University School of Medicine, Malatya, Turkey

Corresponding author

ABSTRACT

Osteogenesis Imperfecta (OI) results from gene mutation that causes defective or insufficient collagen formation. It may cause various anesthetic complications due to the difficulty in airway management, existence of spinal deformity, respiratory disorders, cardiac anomalies, thrombocyte function disorder, risk of hyperthermia, bacillary invagination, bone deformities and metabolic disorders. The anesthesia management of OI patients should be exercised with caution given certain risks of respiratory disorders. These risks are due to thorax deformity, bone fractures during moving or changing position, mandibular and cervical fractures related with intubation, difficult intubation and malignant hyperthermia. The anesthetic technique using Total Intravenous Anesthesia (TIVA) and laryngeal mask airway is suitable for pediatric patient care with OI. However, these techniques have not yet been reported as useful in neurosurgery case reports. In this study, we present the use of TIVA and ProSeal Laringeal Mask in a child with OI and epidural hemorrhage. We came to the conclusion that LMA and TIVA can safely be used in the anesthetic management of OI patients with severe anesthetic problems.

Keywords: Anesthesia; Anesthesia, Intravenous; Hematoma, Epidural, Cranial; Laryngeal Masks; Osteogenesis Imperfect.

Introduction

Osteogenesis Imperfecta (OI) is a hereditary disease of connective tissues that develops depending on the mutation of the Type I collagen gene. Approximately one in every 30,000 births manifest this disease1. Primary bone lesion is characterized with the absence of normal ossification in endochondral bone. As a result, bones become very fragile. Besides fragile bones, one can observe teeth anomalies, hearing disorder, blue sclera, macrocephaly, kyphoscoliosis, thrombocyte function disorder, respiratory dysfunction based on chest deformity, metabolic disorders and growth deficiency1,2. OI cases generally require orthopedic surgery due to bone fracture. Even though a direct relationship between OI and malignant hyperthermia has not been proven, malignant hyperthermia symptom and findings have been observed in the OI case under general anesthesia3. The anesthesia management of OI patients should be exercised with caution, given there are risks of respiratory disorders due to thorax deformity, bone fractures during moving or changing position, mandibular and cervical fractures related intubation, difficult intubation and malignant hyperthermia. In this study, we present the use of Total Intravenous Anesthesia (TIVA) and ProSeal Laryngeal Mask (PLMA) in a child with OI and epidural hemorrhage.

Case Report

Operation was planned for the case of a 7-year-old girl weighing 10kg due to epidural hematoma. The parents were 3rd degree relatives and we determined no pathology in the family. Severe growth retardation, bone deformities on lower and upper extremities due to old fractures, scoliosis and chest deformity were present in the physical examination (Figure 1). Head and neck movements were limited leading to a Mallampati III score. The patient was agitated, but with a Glasgow coma score of 15 points. Preoperative full blood count, coagulation profile, biochemical and blood gas analysis were normal, apart from 10.2 g.dL-1 hemoglobin. Epidural hematoma was present in the right parietal region in computer tomography (Figure 2).



Considering the development of malignant hyperthermia during the patient's anesthesia preparation; dantrolene sodium, sodium bicarbonate and cold intravenous serums were prepared. We considered bispectral index monitorization in order to determine the anesthetic depth, however this was not carried out since the patient was going to be operated from her parietofrontal region. We avoided the use of agents that might trigger malignant hyperthermia such as halothane, enflurane and succinylcholine. Propofol and remifentanil was prepared for TIVA. We prepared laryngeal mask airway (LMA) of various sizes (ProSeal LMA, laryngeal Mask Company, Herley on Thames, UK).

The patient was taken to the operating room without premedication where electrocardiography, pulse oximeter, noninvasive blood pressure and rectal temperature monitorization were carried out. The readings were SpO2 96%, heart rate 132 beat.min-1, noninvasive arterial blood pressure 90/57 mm Hg, rectal body temperature 36.8ºC. Following a 5-minute preoxygenation, anesthesia was induced with 2.5 mg.kg-1 propofol and 1 µg.kg-1 remifentanil; the anesthesiologist inserted a PLMA numbered 1.5 while carefully holding the patient's head in neutral position in order not to damage the lower jaw and teeth. Following gastric aspiration via the PLMA drainage tube using a nasogastric catheter, the esophagus probe was affixed in order to measure the esophagus temperature concurrently with the rectal temperature. Anesthesia was maintained with propofol infusion 4 mg/kg/h, remifentanil 0.25 µg.kg-1.min-1. The propofol and remifentanil doses applied in accordance to the patient's hemodynamic data varied between 4-10 mg.kg-1.h-1 and 0.25-0.5 µg.kg-1.min-1, respectively.

Anesthesia was maintained with 50% O2 and 50% air mixture. We used synchronized intermittent ventilation mode with low tidal volume to avoid chest bone fracture. Esophagus and rectal temperatures ranged between 36-37.1ºC during the operation, which lasted about 120 minutes. We administered 100 mL erythrocyte transfusion to the case with a total hemorrhage of 100 mL during the intraoperative period. Saturation did not fall below 97% during the operation and the heart rate and blood pressure varied from their respective pre-operation values by ± 20%. We gave intravenous paracetamol 15 minutes before the end of the operation. The arterial blood gas analysis performed at the end of the operation was normal, SpO2 100%, heart rate was 116 beat.min-1, noninvasive arterial blood pressure was 87/63 mm Hg and rectal body temperature was 36.4ºC. We pulled the patient's PLMA after deflation of the cuff, once she had sufficient spontaneous respiration and protective airway reflexes. The patient was taken to the intensive care unit.

Discussion

OI results from gene mutation that causes defective or insufficient collagen formation1. It may cause various anesthetic complications due to the difficulty in airway management, existence of spinal deformity, respiratory disorders, cardiac anomalies, thrombocyte function disorder, risk of hyperthermia, bacillary invagination, bone deformities and metabolic disorders4.

One should exercise care during the perioperative period of OI patients' transportation, placement on the operation table and positioning; parts under pressure should be supported using soft peds. Excessively fragile bones could cause perioperative morbidity. Neck and mandibular fracture may occur during the laryngoscopy due to excessive extension of the neck. Fasciculation induced by succinylcholine may cause fractures. Kyphoscoliosis and thoracic deformities may restrict neck movements, thus, making it difficult to see the larynx. The risk of tooth loss in patients with dentinogenesis imperfecta is high. We advise preoperative determination of mouth and teeth anomalies and the use of mouth protectors for teeth protection on these patients2.

The use of LMA for the airway control of OI cases is preferred to prevent the complications that might arise during tracheal intubation5,6. LMA can prevent possible bone fractures due to movement and waking up by soft extubation5. We applied PLMA on our patient with head trauma considering the complications that might arise during intubation and extubation. We prevented sympathoactivation that might have occurred with endotracheal intubation and secure airway was obtained without any complication.

Fiberoptic intubation would appear to be a method of securing the airway. Other methods for maintaining cervical spine immobility during intubation include the use of an intubating laryngeal mask airway or of a stylet4. Tracheal intubation through intubating laryngeal mask may be safer for securing the airway during neurosurgery. However, a laryngeal mask may be an alternative approach for neurosurgery.

Porsborg et al.3 believe that malignant hyperthermia has developed in the patient on whom they performed general anesthesia using barbiturate, fentanil, pancuronium and nitrous oxide. However, they stated that the in vitro contractor test they performed later was normal. They have concluded that the hypermetabolic condition they observed of OI patients is a result of unknown mechanisms aside from malignant hyperthermia. In a retrospective study on the effects of various anesthesia methods on intra and postoperative body temperature of OI patients, Fulderer et al.7 observed that body temperatures in the group in which TIVA was used decreased, whereas, the body temperatures of the group on which enflurane was used have increased. However, Santo et al.6 stated that they have observed no increase in temperature on patients on whom sevoflurane anesthesia was used. TIVA anesthesia and LMA application are suggested as safe methods in terms of malignant hyperthermia and traumatic complications5,8,9.

The anesthetic management using TIVA and laryngeal mask airway is suitable for caring for pediatric patients with OI5,6,8,9. However, these techniques have not yet been reported to be useful in neurosurgery case reports. We observed no complication during or after the PLMA application in our OI case with epidural hemorrhage on whom we applied TIVA and, in addition, did not observe intraoperative or postoperative hyperthermia or hypermetabolic condition.

In conclusion, we think that LMA and TIVA can safely be used in the anesthetic management of OI patients with severe anesthetic problems.

References

  • 1. Bissonnette B, Luginbuehl I, Marciniak B, Dalens B - Osteogenesis imperfekta, syndromes. 1st ed. New York: McGraw-Hill Medical Publishing Division. 2005;618-621.
  • 2. Baum VC. O'Flaherty JE - Anesthesia for genetic, metabolic, and dysmorphic syndromes of childhood. 2nd ed. Philadelphia: Lippincott Williams & Wilkins. 2007;283-285.
  • 3. Porsborg P, Astrup G, Bendixen D, Lund AM, Ording H -Osteogenesis imperfekta and malingnant hyperthermia. Is there a relationship? Anaesthesia. 1996;51:863-865.
  • 4. Oakley I, Reece LP - Anesthetic implications fort the patient with osteogenesis imperfecta. AANA Journal. 2010;78:47-53.
  • 5. Ogawa S, Okutanı R, Suehıro K - Anesthetic management using total intravenous anaesthsia with remifentanil in a child with osteogenesis imperfecta. J Anesth. 2009;23:123-125.
  • 6. Santos ML, Anez C, Fuentes A, Mendez B, Perinan R, Maria R - Airway management with ProSeal LMA in a patient with osteogenesis imperfecta. Anesth Analg. 2006;103:794.
  • 7. Fulderer S, Stanek A, Karbowski A, Eckardt A - Intraoperative hyperpyrexia in patients with osteogenesis imperfecta. Z Orthop ıhr Grenzgeb. 2000;138:136-139.
  • 8. Kostopanagiotou G, Coussi T, Tsaroucha N, Voros D - Anaesthesia using a larygeal mask airway in a patient with osteogenesis imperfecta. Anaesthesia. 2000;55:506.
  • 9. Karabıyık L, Parpucu M, Kurtipek O - Total intravenous anaesthesia and the use of an intubating laryngeal mask in a patient with osteogenesis imperfecta. Acta Anaesthesiol Scand. 2002;46:618-619.
  • Anesthesia management in a child with osteogenesis imperfecta and epidural hemorrhage

    Mehmet Ali ErdoğanI; Mukadder SanliII; Mehmet Ozcan ErsoyII
  • Publication Dates

    • Publication in this collection
      22 July 2013
    • Date of issue
      Aug 2013

    History

    • Received
      05 June 2012
    • Accepted
      16 July 2012
    Sociedade Brasileira de Anestesiologia R. Professor Alfredo Gomes, 36, 22251-080 Botafogo RJ Brasil, Tel: +55 21 2537-8100, Fax: +55 21 2537-8188 - Campinas - SP - Brazil
    E-mail: bjan@sbahq.org